v3.26.1
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Jun. 04, 2026
Mar. 04, 2026
Restructuring Cost and Reserve [Line Items]    
Net working capital other than cash and restricted deposits   $ 211
Property and equipment   9
Goodwill   14,329
In-process research and development, net of deferred taxes   508
Non-controlling interests   (79)
Total consideration   (15,171)
Net cash acquired   $ (193)
CliniQuantum [Member]    
Deconsolidation of subsidiary upon loss of control (see note 6.D):    
Net working capital other than cash and restricted deposits $ 100  
Recognition of investment accounted for using the equity method 3,840  
Non-controlling interests 11  
Gain arising from deconsolidation upon loss of control (3,831)  
Net cash deconsolidated upon loss of control $ 120